Breast Cancer Prognosis: A Literature Review

被引：0
作者：
Akbari, Hamed [1 ]
Alavi, Seyed Ali [2 ]
机构：
[1] Kerman Univ Med Sci, Physiol Res Ctr, Inst Neuropharmacol, Kerman, Iran
[2] Hormozgan Univ Med Sci, Student Res Comm, Bandar Abbas, Iran
来源：
RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES | 2015年 / 6卷 / 02期
关键词：
Breast cancer; prognosis; review article;
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Breast cancer is the most prevalent malignancy among women in all around the world. Every year substantial numbers of women develop to this malignancy. Study about effective factors on survival and prognosis of these patients can lead to promote the quality of treatment protocols. There are some known genetic factors, drugs, environmental or nutritional factors those effect on prognosis of breast cancer. So in this review article, we decided to discuss about prognosis of patients with breast cancer and it's effective factors.
引用
收藏
页码：1426 / 1430
页数：5
相关论文
共 13 条
  • [1] Prognosis of Women With Primary Breast Cancer Diagnosed During Pregnancy: Results From an International Collaborative Study
    Amant, Frederic
    von Minckwitz, Gunter
    Han, Sileny N.
    Bontenbal, Marijke
    Ring, Alistair E.
    Giermek, Jerzy
    Wildiers, Hans
    Fehm, Tanja
    Linn, Sabine C.
    Schlehe, Bettina
    Neven, Patrick
    Westenend, Pieter J.
    Mueller, Volkmar
    Van Calsteren, Kristel
    Rack, Brigitte
    Nekljudova, Valentina
    Harbeck, Nadia
    Untch, Michael
    Witteveen, Petronella O.
    Schwedler, Kathrin
    Thomssen, Christoph
    Van Calster, Ben
    Loibl, Sibylle
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) : 2532 - +
  • [2] TUMOR BIOLOGIC FACTORS AND BREAST-CANCER PROGNOSIS AMONG WHITE, HISPANIC, AND BLACK-WOMEN IN THE UNITED-STATES
    ELLEDGE, RM
    CLARK, GM
    CHAMNESS, GC
    OSBORNE, CK
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (09) : 705 - 712
  • [3] Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908
    Frasci, G.
    D'Aiuto, G.
    Comella, P.
    D'Aiuto, M.
    Di Bonito, M.
    Ruffolo, P.
    Iodice, G.
    Petrillo, A.
    Lastoria, S.
    Oliviero, P.
    Capasso, I.
    Montella, M.
    Siani, C.
    Santangelo, M.
    Vizioli, L.
    Comella, G.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (04) : 707 - 716
  • [4] Grb14 as an Independent Good Prognosis Factor for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Huang, Ou
    Jiang, Min
    Zhang, Xi
    Xie, Zuoquan
    Chen, Xiaosong
    Wu, Jiayi
    Liu, Hongchun
    Shen, Kunwei
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (11) : 1064 - 1072
  • [5] Effects of Differential Distribution of Microvessel Density, Possibly Regulated by miR-374a, on Breast Cancer Prognosis
    Li, Jian-Yi
    Zhang, Yang
    Zhang, Wen-Hai
    Jia, Shi
    Kang, Ye
    Tian, Rui
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (03) : 1715 - 1720
  • [6] Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome
    Lobbezoo, Dorien J. A.
    van Kampen, Roel J. W.
    Voogd, Adri C.
    Dercksen, M. Wouter
    van den Berkmortel, Franchette
    Smilde, Tineke J.
    van de Wouw, Agnes J.
    Peters, Frank P. J.
    van Riel, Johanna M. G. H.
    Peters, Natascha A. J. B.
    de Boer, Maaike
    Borm, George F.
    Tjan-Heijnen, Vivianne C. G.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 141 (03) : 507 - 514
  • [7] Somatic Mutation Profiling and Associations With Prognosis and Trastuzumab Benefit in Early Breast Cancer
    Loi, Sherene
    Michiels, Stefan
    Lambrechts, Diether
    Fumagalli, Debora
    Claes, Bart
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Bono, Petri
    Kataja, Vesa
    Piccart, Martine J.
    Joensuu, Heikki
    Sotiriou, Christos
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (13): : 960 - 967
  • [8] Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: Improved prognosis in triple-negative tumors
    Medioni J.
    Huchon C.
    Le Frere-Belda M.-A.
    Hofmann H.
    Bats A.-S.
    Eme D.
    Andrieu J.-M.
    Oudard S.
    Lecuru F.
    Levy E.
    [J]. Drugs in R & D, 2011, 11 (2) : 147 - 157
  • [9] Vitamin D Receptor Gene Polymorphisms and Prognosis of Breast Cancer among African-American and Hispanic Women
    Mishra, Dhruva K.
    Wu, Yanyuan
    Sarkissyan, Marianna
    Sarkissyan, Suren
    Chen, Zujian
    Shang, Xiying
    Ong, May
    Heber, David
    Koeffler, H. Phillip
    Vadgama, Jaydutt V.
    [J]. PLOS ONE, 2013, 8 (03):
  • [10] Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer
    Saquib, Juliann
    Parker, Barbara A.
    Natarajan, Loki
    Madlensky, Lisa
    Saquib, Nazmus
    Patterson, Ruth E.
    Newman, Vicky A.
    Pierce, John P.
    [J]. COMPLEMENTARY THERAPIES IN MEDICINE, 2012, 20 (05) : 283 - 290
12